期刊文献+

奥曲肽治疗晚期癌症并发肠梗阻30例 被引量:3

原文传递
导出
摘要 目的 研究奥曲肽对晚期癌症患者并发肠梗阻的治疗作用.方法 将恶性肠梗阻患者60例分为两组,对照组30例,给予禁饮食、鼻胃管减压、镇痛、补液支持等常规治疗 治疗组30例,在常规治疗的基础上加用奥曲肽0.1 mg/次,皮下注射,1次/8 h.观察治疗第4天、第7天临床症状改善情况、胃肠减压引流量、胃管拔除率以及不良反应等指标.结果 治疗组23例、对照组8例治疗4d后临症状改善,胃肠减压引流量:治疗组(385±153)ml/d,对照组(854±309)ml/d,治疗第7天后治疗组26例与对照组10例临床症状改善,胃肠减压引流量:治疗组(80±165)ml/d,对照组(585±257)ml/d 胃管拔除率:治疗组78.9%、对照组33.3%.无不良反应.结论 常规治疗联合奥曲肽对恶性肠梗阻有明显的改善症状、减少胃肠液分泌量的作用,疗效优于常规治疗.
出处 《肿瘤研究与临床》 CAS 2010年第7期496-497,共2页 Cancer Research and Clinic
  • 相关文献

参考文献7

  • 1Ripamonti C,Twycross R,Baines M,et al.Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer.Support Care Cancer,2001,9:223-233.
  • 2陈彻,李幼生.恶性肠梗阻的治疗[J].实用临床医药杂志,2005,9(9):43-45. 被引量:18
  • 3Wright HK,Orieu JJ,Tilson MD.Water absorption in experimental closed segment obstruction of ileum in man.Am J Surg,1971,121:96-99.
  • 4Ripamonti C,Panzeri C,Croff L,et al.The role of somatostatin and octretide in bowel obstruction:pre-clinical and clinical results.Tumori,2001,87:1-9.
  • 5Andrew D.The palliative effects of octreotide in cancer patients.Chemotherapy,2001,47:54-61.
  • 6李健,金懋林,沈琳.醋酸奥曲肽在恶性肿瘤肠梗阻中的应用[J].中华胃肠外科杂志,2007,10(5):479-481. 被引量:14
  • 7de Herder WW,Lambrets SW.Somatostatin and somatostatin analogues:diagnostic and therapeutic uses.Curr Opin Oncol,2002,14:53-57.

二级参考文献32

  • 1Ripamonti C,Bruera E. Palliative management of malignant bowel obstruction[J]. Int J Gynecol Cancer,2002,12(2): 135.
  • 2Carla R,Robert T,Mary B,et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer[J]. Support Care Cancer,2001,9: 223.
  • 3Fainsinger R L,Spachynski K,Hanson J,et al. Symptom control in terminally ill patients with malignant bowel obstruction[J]. J Pain Symptom Manage,1994,9: 12.
  • 4Ventafridda V,Ripamonti C,Caraceni A,et al. The management of inoperable gastroin-testinal obstruction in terminal cancer patients[J]. Tumori,1990,76: 389.
  • 5Mercadante S. Pain in inoperable bowel obstruction. Pain Digest,1995,5: 9.
  • 6Feuer D J,Broadley,K E,Shepherd J H,Barton D P. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer[J]. Gynecol Oncol,1999,75: 313.
  • 7Higashi H,Shida H,Ban K,Yamagata S,Masuda K,Imanari T,Yamamoto T. Factors affecting successful palliative surgery for malignant bowel obstruction due to peritoneal dissemination from colorectal cancer[J]. Jpn J Clin Oncol,2003,33(7): 357.
  • 8Blair S L,Chu D Z,Schwarz R E. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer[J]. Ann Surg Oncol,2001,8(8): 632.
  • 9Woolfson R G,Jennings K,Whalen G F. Management of bowel obstruction in patients with abdominal cancer[J]. Arch Surg,1997,132: 1093.
  • 10Harris G J C,Senagore A J,Lavery I C,Fazio V W. The management of neoplastic colorectal obstruction with colonic endoluminal stenting devices[J]. Am J Surg,2001,181: 499.

共引文献30

同被引文献37

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部